Replies to post #201616 on Biotech Values

[DewDiligence]

AVIR resumes enrollment in phase-2a RSV trial:

http://finance.yahoo.com/news/aviragen-therapeutics-resumes-enrollment-phase-110000475.html

Enrollment had been halted on 5/26/16 (#msg-122931950). The resumption of enrollment in this trial allows AVIR to proceed with the submission for a US IND.